Company: PAII-WT
Filing Date: 2025-05-29
Form Type: DRS
Source: 0001213900-25-049013
Chunk: 259

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-05-29
Form: DRS
Chunk 259
---
 of this offering would be a maximum of 20,125,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 26.5% of the outstanding shares after this offering. Up to 946,428 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised. If we increase or decrease the size of the offering, we will effect a share capitalization or a share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of this offering in such amount as to maintain the number of founder shares, on an as -convertedbasis, at 26.5% of our issued and outstanding ordinary shares upon the consummation of this offering. Our sponsor has committed to purchase an aggregate of 5,050,000 private placement warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $5,050,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. The private placement warrants will be identical to the warrants sold in this offering except that the private placement warrants (i) will not be redeemable by us, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. Certain accredited investors (which may include certain of our directors and officers other than Messrs. Duroc -Dannerand Gustafson), (the “non -managingsponsor investors”) have expressed an interest to purchase, indirectly through the purchase of non -managingsponsor membership interests, an aggregate of [•] of the 5,050,000 total private placement warrants to be purchased and [•] of the 7,255,952 total founder shares held by our sponsor, assuming the underwriters’ over -allotmentoption is exercised in full. Prior to or in connection with the completion of our initial business combination, there may be payment by the company to our officers, independent directors, advisors, or their respective affiliates, of a finder